iTransition Development
iTransition: Pilot Testing a Multilevel Technology Based Intervention to Support Youth Living With HIV From Adolescent to Adult Care
2 other identifiers
interventional
78
1 country
3
Brief Summary
Youth living with HIV are at high risk of falling out of care when they transition from pediatric to adult care. The investigators are proposing to develop a mobile app to help both clinical providers and patients navigate this process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedStudy Start
First participant enrolled
August 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedResults Posted
Study results publicly available
August 13, 2025
CompletedAugust 13, 2025
August 1, 2025
3.8 years
May 7, 2020
June 27, 2025
August 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Linkage to Adult Care
Defined dichotomously as having one completed adult clinic appointment or not.
18 month post-intervention
Secondary Outcomes (2)
Care Retention Per Each 6-month Period
Baseline, 6 month post-intervention, 12 month post-intervention, 18-month post-intervention
Number of Participants With Viral Suppression
Baseline, 1-year post-intervention
Study Arms (4)
YLH Historical Control Group
NO INTERVENTIONParticipants in this group will have the following phases: * Screening * Single visit assessment
YLH iTransition Intervention Group
EXPERIMENTALParticipants in this group will have the following phases: * Screening * Baseline Visit * Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3 and 9 month
Provider Group
EXPERIMENTALParticipants in this group will have the following phases: * Screening * Baseline Visit * Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3, 9 and 15 month
Transition Champion Group
EXPERIMENTALParticipants in this group will have the following phases: * Screening * Baseline Visit and Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3, 9 and 15 month
Interventions
Is a mobile website application (app), and it can be used on a range of devices (computer, tablet, smartphone) and operating systems (iOS, Android, Windows). Features of iTransition will include, but are not limited to: medication reminders, calendar tracking of appointments, direct messaging between youth and providers, and privacy password lock.
Eligibility Criteria
You may qualify if:
- For YLH Historical Control Group
- YLH (regardless of gender/assigned sex at birth) age ≥ 18 years;
- Has plan for HCT within next 6 months;
- Enrolled in care at Grady IDP pediatric/adolescent clinic or CHOP AI/SI clinics.
- For YLH iTransition Intervention Group
- YLH (regardless of gender/assigned sex at birth) age ≥ 18 years;
- Has plan for HCT within next 6 months;
- Enrolled in care at Grady IDP pediatric/adolescent clinic or CHOP AI/SI clinics;
- Owns a smartphone and/or tablet
- Reports consistent internet access (defined as no lapse \>24 hours in last 6 months) via their smartphone or tablet.
- For Provider Group
- Staff member at Grady IDP (pediatric/adolescent clinic, adult women's clinic, and/or adult men's clinic), CHOP AI/SI clinics, UPHS: HUP or Presby infectious disease clinics;
- Works with transitioning YLH;
- Access to internet via any device (e.g., smartphone, tablet, computer);
- Endorse participation in the HCT process.
- +6 more criteria
You may not qualify if:
- Youth who are \<18 years old;
- Youth who are not living with HIV;
- Transition is not expected (from pediatric/adolescent to adult care) within the next 6 months;
- Presence of serious psychiatric symptoms (e.g., active hallucinations, thought disorder) that would impair the individual's ability to provide true informed consent or participate in the study activities;
- Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior) at the time of consent.
- For YLH iTransition Intervention Group
- Youth who are \<18 years old;
- Youth who are not living with HIV;
- Transition is not expected (from pediatric to adult care) within the next 6 months;
- Does not own smartphone/tablet and has inconsistent internet access (i.e. has had one or more lapse \>24 hrs in the last three months);
- Presence of serious psychiatric symptoms (e.g., active hallucinations, thought disorder) that would impair the individual's ability to provide true informed consent or participate in the study activities;
- Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior) at the time of consent.
- For Provider Group
- Not a staff member at Grady IDP, CHOP SI/AI, UPHS: HUP or Presby infectious disease clinics;
- Does not work with transitioning YLH;
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (3)
Grady Hospital
Atlanta, Georgia, 30303, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
University of Pennsylvania Health System - HUP and Presby infectious disease clinics
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Sophia Hussen
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Sophia Hussen, MD
Emory University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 7, 2020
First Posted
May 12, 2020
Study Start
August 28, 2020
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
August 13, 2025
Results First Posted
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data is expected to become available in September 2022 upon completion of the study.
- Access Criteria
- Data will not be deposited into a public repository, but will be made available upon request to the principal investigator. The PI will discuss requests with the other study team members, and make a determination about whether data can be shared.
Survey data will be shared as well as de-identified clinical outcome data Study protocols and statistical analysis plans upon request